BioRestorative Therapies, Inc.

BRTX - Company ID 0001505497

Market cap-

Rank-

Filings735

BioRestorative Therapies, Inc. has filed 735 public company documents between 2010 and 2026. The most frequent type is insider trade (261 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchBRTX overviewCompany snapshotMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyLive rankingSee the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with DVAPeer viewPut BRTX beside DVA across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow BRTX via RSS

Similar companies to research next

DVADaVita Inc.

FMSFresenius Medical Care AG SSHCSotera Health Company

PGNYProgyny, Inc.

AGLagilon health, inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
SCHEDULE 13G/A	SCHEDULE 13G/A	8mo ago2025-12-19	-	View filing
DRS	DRS	8mo ago2025-12-19	-	View filing
424B3	424B3	9mo ago2025-12-12	-	View filing
EFFECT	EFFECT	9mo ago2025-12-10	-	View filing
CORRESP	Company correspondence	9mo ago2025-12-08	-	View filing
S-8	Employee stock plan	9mo ago2025-11-18	-	View filing
S-1	IPO registration	9mo ago2025-11-18	-	View filing
10-Q	Quarterly report	10mo ago2025-11-12	2025-09-30	View filing
8-K	Major company event	10mo ago2025-11-12	2025-11-12	View filing
4	Insider trade	10mo ago2025-10-20	2025-10-06	View filing
4	Insider trade	10mo ago2025-10-20	2025-10-06	View filing
D	D	11mo ago2025-10-09	-	View filing
8-K	Major company event	11mo ago2025-10-08	2025-10-06	View filing
424B5	Prospectus supplement	11mo ago2025-10-08	-	View filing
424B5	Prospectus supplement	11mo ago2025-10-06	-	View filing
8-K	Major company event	11mo ago2025-09-25	2025-09-18	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	1y ago2025-08-14	-	View filing
8-K	Major company event	1y ago2025-08-14	2025-08-14	View filing
10-Q	Quarterly report	1y ago2025-08-12	2025-06-30	View filing
8-K	Major company event	1y ago2025-08-12	2025-08-12	View filing
DEF 14A	Proxy statement	1y ago2025-08-08	2025-08-08	View filing
8-K	Major company event	1y ago2025-06-13	2025-06-13	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	1y ago2025-05-15	-	View filing
10-Q	Quarterly report	1y ago2025-05-14	2025-03-31	View filing
8-K	Major company event	1y ago2025-05-14	2025-05-14	View filing
8-K	Major company event	1y ago2025-04-21	2025-04-16	View filing
10-K	Annual report	1y ago2025-03-28	2024-12-31	View filing
8-K	Major company event	1y ago2025-03-27	2025-03-27	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	1y ago2025-02-28	-	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	1y ago2025-02-19	-	View filing
SCHEDULE 13D/A	SCHEDULE 13D/A	1y ago2025-02-19	-	View filing
SCHEDULE 13D/A	SCHEDULE 13D/A	1y ago2025-02-19	-	View filing
4	Insider trade	1y ago2025-02-19	2025-02-14	View filing
4	Insider trade	1y ago2025-02-19	2025-02-14	View filing
4	Insider trade	1y ago2025-02-19	2025-02-14	View filing
4	Insider trade	1y ago2025-02-19	2025-02-14	View filing
4	Insider trade	1y ago2025-02-19	2025-02-14	View filing
4	Insider trade	1y ago2025-02-19	2025-02-14	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	1y ago2025-02-10	-	View filing
8-K	Major company event	1y ago2025-02-10	2025-02-10	View filing

BioRestorative Therapies, Inc.

Similar companies to research next

Year